Zynex gains amid report it's pursuing strategic options, including a sale

Zynex (NASDAQ:ZYXI) rose 2% amid a report that the medical device maker is evaluating its options, including a possible sale.

The company is working with Cantor Fitzgerald to review its options, including a takeover, a merger, a divestiture, a recapitalization, or another transaction, according to a Bloomberg report, which cited people familiar.

There’s no certainty that Zynex (ZYXI) will decide to pursue a deal, according to the report. Zynex has a market cap of $283 million.